Charles E. Aldinger

1.2k total citations
13 papers, 1.0k citations indexed

About

Charles E. Aldinger is a scholar working on Molecular Biology, Cell Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Charles E. Aldinger has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Charles E. Aldinger's work include Aldose Reductase and Taurine (7 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Neonatal Health and Biochemistry (3 papers). Charles E. Aldinger is often cited by papers focused on Aldose Reductase and Taurine (7 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Neonatal Health and Biochemistry (3 papers). Charles E. Aldinger collaborates with scholars based in United States, United Kingdom and France. Charles E. Aldinger's co-authors include Thomas A. Beyer, Todd W. Siegel, Lori Royer, Omar L. Francone, Banavara L. Mylari, William J. Zembrowski, John McNeish, Robert J. Aiello, Deborah J. Guyot and Kenneth L. Hoppe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Charles E. Aldinger

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles E. Aldinger United States	10	454	413	288	268	210	13	1.0k
Mary A. Root United States	17	301 0.7×	215 0.5×	106 0.4×	135 0.5×	78 0.4×	40	963
Anne-Lise Pichard France	17	649 1.4×	231 0.6×	98 0.3×	68 0.3×	48 0.2×	26	915
Ernst U. Frevert United States	16	1.2k 2.6×	521 1.3×	136 0.5×	154 0.6×	64 0.3×	24	1.7k
Monica Pibiri Italy	23	685 1.5×	260 0.6×	129 0.4×	221 0.8×	19 0.1×	40	1.4k
Adam M. Fivush United States	7	765 1.7×	531 1.3×	23 0.1×	550 2.1×	119 0.6×	8	1.3k
Thomas P. Beyer United States	16	518 1.1×	772 1.9×	55 0.2×	239 0.9×	35 0.2×	22	1.2k
William R. Bensch United States	16	638 1.4×	580 1.4×	46 0.2×	298 1.1×	38 0.2×	18	1.6k
Tatsuji Shiratori United States	10	693 1.5×	343 0.8×	108 0.4×	65 0.2×	29 0.1×	12	1.1k
Shinji Yoshioka Japan	7	1.1k 2.5×	416 1.0×	76 0.3×	98 0.4×	23 0.1×	8	1.6k
Kenji Ohwaki Japan	18	341 0.8×	122 0.3×	46 0.2×	112 0.4×	101 0.5×	30	866

Countries citing papers authored by Charles E. Aldinger

Since Specialization

Citations

This map shows the geographic impact of Charles E. Aldinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Aldinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Aldinger more than expected).

Fields of papers citing papers by Charles E. Aldinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Aldinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Aldinger. The network helps show where Charles E. Aldinger may publish in the future.

Co-authorship network of co-authors of Charles E. Aldinger

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Aldinger. A scholar is included among the top collaborators of Charles E. Aldinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Aldinger. Charles E. Aldinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kane, Christopher D., Kimberly A. Stevens, Mehrdad Haghpassand, et al.. (2008). Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo. Molecular Pharmacology. 75(2). 296–306. 18 indexed citations

Pruimboom‐Brees, Ingrid, Mehrdad Haghpassand, Lori Royer, et al.. (2006). A Critical Role for Peroxisomal Proliferator-Activated Receptor-α Nuclear Receptors in the Development of Cardiomyocyte Degeneration and Necrosis. American Journal Of Pathology. 169(3). 750–760. 22 indexed citations

McNeish, John, Robert J. Aiello, Deborah J. Guyot, et al.. (2000). High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proceedings of the National Academy of Sciences. 97(8). 4245–4250. 465 indexed citations

Hayward, Cheryl M., E.S. Hamanaka, Robert J. Aiello, et al.. (1997). 2.P.40 Discovery of the squalene synthetase inhibitor CP-340,868. Atherosclerosis. 134(1-2). 125–125. 2 indexed citations

Wester, Ronald T., Christian J. Mularski, Paul Da Silva Jardine, et al.. (1994). Dihydropyridines: a new class of angiotensin II antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 133–138. 3 indexed citations

Lipinski, Christopher A., Charles E. Aldinger, Thomas A. Beyer, et al.. (1992). Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors. Journal of Medicinal Chemistry. 35(12). 2169–2177. 34 indexed citations

Mylari, Banavara L., Thomas A. Beyer, Charles E. Aldinger, et al.. (1992). Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chain. Journal of Medicinal Chemistry. 35(3). 457–465. 28 indexed citations

Mylari, Banavara L., William J. Zembrowski, Thomas A. Beyer, Charles E. Aldinger, & Todd W. Siegel. (1992). Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivatives. Journal of Medicinal Chemistry. 35(12). 2155–2162. 32 indexed citations

Mylari, Banavara L., Eric R. Larson, Thomas A. Beyer, et al.. (1991). Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid (zopolrestat) and congeners. Journal of Medicinal Chemistry. 34(1). 108–122. 222 indexed citations

10.

Peterson, Michael J., et al.. (1986). Applicability of red blood cell sorbitol measurements to monitor the clinical activity of sorbinil. Metabolism. 35(4). 93–95. 11 indexed citations

11.

Malone, John I., et al.. (1984). Red Blood Cell Sorbitol as an Indicator of Polyol Pathway Activity: Inhibition by Sorbinil in Insulin-dependent Diabetic Subjects. Diabetes. 33(1). 45–49. 84 indexed citations

12.

Peterson, M.J., et al.. (1979). Inhibition of Polyol Pathway Activity in Diabetic and Galactosemic Rats by the Aldose Reductase Inhibitor CP-45,634. Advances in experimental medicine and biology. 119. 347–356. 5 indexed citations

13.

Peterson, M.J., et al.. (1979). CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism. 28(4). 456–461. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact